Photo taken from Shannon Westin/X
Mar 26, 2024, 09:45
Shannon Westin: Overall survival is improved in all comers in the RUBY study of Immunotherapy and chemotherapy in advanced/recurrent Endometrial Cancer
Shannon Westin, Professor at Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center, shared a post on X/Twitter:
“Overall survival is improved in all comers in the RUBY study of Immunotherapy and chemotherapy in advanced/recurrent Endometrial Cancer – 31% reduction in risk of death consistent with 16 month improvement!!!”
Source: Shannon Westin/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 2, 2024, 21:41
Nov 2, 2024, 21:25
Nov 2, 2024, 21:06
Nov 2, 2024, 20:51